Literature DB >> 10713050

Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells.

J F Lai1, S C Kao, S T Jiang, M J Tang, P C Chan, H C Chen.   

Abstract

Focal adhesion kinase (FAK) has been implicated to play a critical role in integrin-mediated control of cell behavior. However, it is unclear whether FAK also participates in the regulation of growth factor-elicited cellular functions. In this study, we have demonstrated that although overexpression of FAK in Madin-Dardy canine kidney cells did not alter their growth property or ability to form tubules within collagen gel upon hepatocyte growth factor (HGF) stimulation, it apparently enhanced HGF-induced cell scattering. This enhancement was largely because of an increase in the third phase (i.e. cell migration) of cell scattering rather than the first two phases (i.e. cell spreading and cell-cell dissociation). Conversely, the expression of FAK-related nonkinase significantly ( approximately 60%) inhibited HGF-induced cell migration. Moreover, we have found that the effect of FAK on promoting HGF-induced cell motility was greatly dependent on cell-matrix interactions. We showed that HGF treatment selectively increased the expression of integrins alpha(2) and, to a lesser extent, alpha(3) in Madin-Dardy canine kidney cells and that a monoclonal antibody against integrin alpha(2) efficiently blocked HGF-enhanced cell migration on collagen. In our efforts to determine the mechanism by which FAK promotes HGF-induced cell migration, we found that FAK mutants deficient in phosphatidylinositol 3-kinase or p130(Cas) binding failed to promote HGF-induced cell migration. Interestingly, cells expressing a FAK mutant defective in Grb2 binding exhibited a rate of migration approximately 50% lower than that of cells expressing wild type FAK in response to HGF stimulation. Taken together, our results suggest a link between HGF-increased integrin expression, FAK activation, and enhanced cell motility and implicate a role for FAK in the facilitation of growth factor-induced cell motility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713050     DOI: 10.1074/jbc.275.11.7474

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.

Authors:  Shu-Yi Chen; Hong-Chen Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 2.  Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.

Authors:  Patricia J Keely
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-07       Impact factor: 2.673

3.  Two distinct signaling pathways in hair cycle induction: Stat3-dependent and -independent pathways.

Authors:  S Sano; M Kira; S Takagi; K Yoshikawa; J Takeda; S Itami
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.

Authors:  Liping Huang; Yifei Qin; Qiang Zuo; Kavita Bhatnagar; Jingbo Xiong; Glenn Merlino; Yanlin Yu
Journal:  Int J Cancer       Date:  2017-12-15       Impact factor: 7.396

Review 5.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

Review 6.  Grb2 signaling in cell motility and cancer.

Authors:  Alessio Giubellino; Terrence R Burke; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

7.  Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation.

Authors:  Deeba N Syed; Farrukh Afaq; Sami Sarfaraz; Naghma Khan; Rajendra Kedlaya; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-09       Impact factor: 4.219

Review 8.  MET pathway as a therapeutic target.

Authors:  Eric S Kim; Ravi Salgia
Journal:  J Thorac Oncol       Date:  2009-04       Impact factor: 15.609

9.  Aberrant cell adhesion molecule expression in human bronchopulmonary sequestration and congenital cystic adenomatoid malformation.

Authors:  Maryann V Volpe; Eunice Chung; Jason P Ulm; Brian F Gilchrist; Steven Ralston; Karen T Wang; Heber C Nielsen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

10.  Deubiquitinase activities required for hepatocyte growth factor-induced scattering of epithelial cells.

Authors:  Richard Buus; Monica Faronato; Dean E Hammond; Sylvie Urbé; Michael J Clague
Journal:  Curr Biol       Date:  2009-08-20       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.